Document:

Exhibit 101

		

			Exhibit 10.1

		

		
			SEPARATION AGREEMENT AND GENERAL RELEASE
		

		
			This Separation Agreement and General Release (“Agreement”), dated March 6, 2017, is entered into by you, Alan J. M. Haughie, on behalf of yourself, your heirs, executors, administrators, successors, assigns (collectively, “you”) and The ServiceMaster Company, LLC, on behalf of itself, subsidiaries, parent companies, affiliated entities, predecessors, successors, assigns, and their respective officers, directors, employees, insurers and agents (collectively, “Company” or “ServiceMaster”).  In consideration of the mutual covenants in this Agreement, the parties hereby agree as follows:
		

		
			1.Separation from Employment.  You have resigned your position as chief financial officer of ServiceMaster, effective on the close of business February 24, 2017.  You resign your employment with the Company, effective March 15, 2017 (“Separation Date”), and will no longer hold any other officer or director position with ServiceMaster or any of its subsidiaries or affiliated entities.  You will continue to be paid your current base salary and benefits through your Separation Date in accordance with ServiceMaster’s normal payroll practices.
		

		
			2.Severance Benefits.  In exchange for your promises as set forth in this Agreement and subject to your compliance with the terms and conditions hereof, ServiceMaster agrees to provide you with the following severance pay:
		

		
			a.Monthly Salary.  You will receive payments totaling $575,000, which equals 12 times your current monthly base salary (the “Monthly Salary”);
		

		
			b.ABP Bonus.  You will be receive a bonus payout (the “ABP Bonus”) under The ServiceMaster Annual Bonus Plan (“ABP”) for the 2016 Plan year in the amount of $277,725, which will be paid on March 15, 2017, subject to the terms and conditions of the ABP;
		

		
			c.Target Bonus.  You will receive payments totaling $402,500 (the “Target Bonus”), which equals your target bonus under the ABP for the 2017 Plan year;
		

		
			d.COBRA Premiums.  A one‐time lump sum payment equal to your COBRA premiums for 12 months based on your current benefit elections.  You will receive this payment on the first practicable payroll date after the Effective Date (as defined in Section 19 below).
		

		
			The Monthly Salary and the Target Bonus will be aggregated as a single sum and paid in 12 equal monthly installments over a 12‐month period, starting on the first practicable payroll date after the Effective Date.  All compensation contemplated by this Agreement will be subject to applicable payroll taxes, income taxes and other authorized withholdings and deductions.
		

		
			Except as otherwise expressly specified in this Agreement, the compensation set forth in paragraph 2 above represents all of the amounts you will be entitled to receive from the Company and you will not be paid any other compensation or benefits.  In addition to any other remedies which may be available at law, the Company may suspend, cancel and/or seek the refund of any compensation contemplated by this Agreement upon any violation by you of any representation, warranty or covenant set forth herein.
		

		 

 

		

			 

		

		

			 

		

		
			3.Outplacement.  You will be eligible for executive‐level outplacement services with a third party vendor for a period of 12 months, subject to the terms and conditions of ServiceMaster’s outplacement program.  If you wish to initiate outplacement services, you must do so no later than 60 days after your Separation Date by calling 1‐877‐700‐7220, ext. 888 or go to www.lhh.com/register.
		

		
			4.Other Benefits.  Upon separation of employment, you may be eligible for payout or benefits under the following policies, compensation plans and benefit plans, even if you do not sign this Agreement:
		

		
			a.Group Health Insurance.  If you participate in or are eligible to participate in the ServiceMaster Health and Welfare Benefit Plan, your eligibility to participate will end on your last day of employment.  You will become eligible for continuation of coverage under COBRA on the first day following your Separation Date.  You are solely responsible for the payment of any premiums for COBRA coverage.
		

		
			b.Paid Time Off.  You will receive payment for any accrued, unused vacation time on or before the next pay date following your Separation Date.
		

		
			c.PSRP.  If you participate in the ServiceMaster Profit Sharing and Retirement Plan (“PSRP”), your eligibility to participate will end on your Separation Date.  Any Company match credited to your account will follow the PSRP’s vesting schedules.  Any amounts to be paid, distributed, rolled over, or held under the PSRP will be paid, distributed, rolled over, or held in accordance with the terms of the PSRP and applicable rules and regulations.
		

		
			d.Stock Plans.  If you participate in any ServiceMaster stock plans, including the ServiceMaster Employee Stock Purchase Plan, the Amended and Restated ServiceMaster Global Holdings, Inc. Stock Incentive Plan, as amended and restated as of October 25, 2012 (“MSIP”), the Amended and Restated ServiceMaster Global Holdings, Inc. 2014 Omnibus Incentive Plan, as amended and restated as of April 27, 2015, and/or the ServiceMaster Global Holdings, Inc. Employee Stock Purchase Plan, any account balances, stock options, restricted stock units or other equity owned by you as of your Separation Date are subject to the terms and conditions of the applicable stock plans.  This Agreement does not change the terms of those plans.
		

		
			5.Release and Covenant Not to Sue.
		

		
			a.Release:  In exchange for the consideration provided to you in this Agreement, you hereby release and forever discharge ServiceMaster, its past and present parent entities, subsidiaries, divisions, limited partnerships, affiliated corporations, successors and assigns, as well as their respective past and present directors, managers, officers, partners, agents, employees, insurers, attorneys, servants, and each of them, separately and collectively (“Releasees”), from any and all claims, charges, complaints, liens, demands, causes of action, obligations, damages and liabilities, known or unknown, suspected or unsuspected, whether or not mature or ripe (“Claims”), that you ever had and now have against any of the Releasees, including, but not limited to, Claims arising out of 
		

		 

		

			2

		

		

			 

		

 

		

			 

		

		

			 

		

		or in any way related to your employment with or separation from the Company.  This includes, but is not limited to, Claims based on statutes, torts, contracts and common law, Claims for discrimination, wrongful discharge, harassment, retaliation, and unpaid wages, Claims arising under Title VII of the Civil Rights Act of 1964, the Fair Labor Standards Act (“FLSA”), Family Medical Leave Act (“FMLA”), the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Worker Adjustment and Retraining Notification Act, the Employee Retirement Income Security Act, and any other federal, state or local law or regulation governing the employment relationship.  You understand that this Agreement includes a release of all known and unknown claims through the Effective Date.  Notwithstanding the above, you are not waiving (i) any claim relating to directors' and officers' liability insurance coverage or any right of indemnification under the Company's organizational documents or otherwise, (ii) your rights under any retirement plan that is "qualified" under Section 401(a) of the Internal Revenue Code of 1986, as amended, or (iii) your rights to non-qualified deferred compensation due under any applicable Company plans in which you have participated.
		

		
			b.Limitation of Release:  Nothing in this Agreement will prohibit you from filing a charge of discrimination with the National Labor Relations Board, the Equal Employment Opportunity Commission (“EEOC”) or an equivalent state civil rights agency, but you agree and understand that you are expressly waiving your right to monetary compensation or damages thereby if any such agency elects to pursue a claim on your behalf.  Further, nothing in this Agreement shall be construed to waive any right that is not subject to waiver by private agreement under federal, state or local employment or other laws, such as claims for workers’ compensation or unemployment benefits or any claims that may arise after the Effective Date.
		

		
			c.Covenant Not To Sue.  To the extent that any Claims covered by the scope of the release herein are not subject to waiver by this Agreement under applicable law (including, without limitation, any Claims arising under or related to FMLA, FLSA, and any other local, state or federal statute governing employment and/or the payment of wages and benefits), you hereby covenant and agree not to sue or otherwise seek any remedy or other form of relief against any of the Releasees relating to such Claims.
		

		
			6.Confidential Information.  You confirm and agree that (a) you have not used or disclosed any Confidential Information other than as necessary in the ordinary course of performing your duties as a ServiceMaster employee for the benefit of ServiceMaster, and (b) you will keep in confidence and trust all Confidential Information known to you, and will not use or disclose such Confidential Information without the prior written consent of ServiceMaster.  As used in this Agreement, “Confidential Information” means ServiceMaster’s trade secrets, proprietary information and/or other non‐public information relating to ServiceMaster’s business operations as well as private, proprietary and/or non¬public information obtained by ServiceMaster from customers, suppliers, contractors, employees or other third parties.  Nothing in this Agreement shall preclude you from reporting suspected unlawful activity to any government agency or providing truthful testimony or information in response to a valid subpoena, court order or request of any government agency.
		

		 

		

			3

		

		

			 

		

 

		

			 

		

		

			 

		

		
			7.Non‐Compete/Non‐Solicitation/Non‐Interference.  While you remain employed by ServiceMaster and for a period of 12 months following your Separation Date, you shall not, directly or indirectly (whether as owner, stockholder, director, officer, employee, principal, agent, consultant, independent contractor, partner or otherwise), in North America or any other geographic area in which ServiceMaster or any subsidiary of ServiceMaster is then conducting business:
		

		
			a.own, manage, operate, control, participate in, perform services for, or otherwise carry on, a business similar to or competitive with the business conducted by ServiceMaster, provided that the foregoing shall not prohibit your passive ownership of less than 1% of any class of voting securities of a public or privately‐held company which would otherwise be prohibited under this Section;
		

		
			b.solicit the business of any customer of ServiceMaster in competition with ServiceMaster;
		

		
			c.induce or attempt to induce any employee of ServiceMaster to terminate his or her employment with ServiceMaster and/or to become employed by any other business or other entity; or
		

		
			d.interfere with ServiceMaster’s relations with any of its customers, franchisees, subcontractors, consultants, suppliers or business partners.
		

		
			This Agreement is in addition to and does not supersede any other agreements prohibiting competition with ServiceMaster.  Failure to abide by this Agreement or other such agreements with the Company will give the Company (in addition to any other remedies which may be available to the Company) the right, exercised in its sole and absolute discretion, to (a) suspend or cancel the payments contemplated in this Agreement and (b) obtain a refund for any such payments already made (collectively, “Company Rights”).  You understand and recognize that, as a result of your executive role with ServiceMaster, you had contact with, and developed and furthered relationships with, customers and/or prospective customers, and had access to secret, proprietary and confidential information regarding ServiceMaster and its businesses, including Confidential Information (as defined above), and therefore understand and agree that (a) both the nature of this covenant and the scope of this covenant, as well as the covenants in Paragraphs 6 and 7 of this Agreement, are reasonable and necessary for the protection of ServiceMaster, including its secret, proprietary and confidential information, goodwill and customer relationships and (b) that ServiceMaster will be irreparably harmed by any breach of Paragraphs 6 and 7, entitling it to seek injunctive and other equitable relief.
		

		
			8.Code of Ethics and Business Conduct.  You previously have been provided or have access through the Company intranet site to the Company Code of Ethics and Business Conduct (the “Code”).  The discovery of any failure by you to abide by the Code, whenever discovered, shall entitle the Company to exercise any and all of its Company Rights, including the suspension and recoupment of any payments paid or due under this Agreement and any other agreements between the parties.  Further, you acknowledge that you are not aware of any material breach of law or regulation by the Company or its subsidiaries that has not been reported to the Audit Committee, Chief Executive Officer or Chief Ethics Officer of the Company.
		

		 

		

			4

		

		

			 

		

 

		

			 

		

		

			 

		

		
			9.Return of ServiceMaster Property.  You agree to return to ServiceMaster all ServiceMaster property, equipment and materials, including, but not limited to, any company vehicle, any laptop computer and peripherals; any cell phone or other portable computing device; any telephone calling cards; keys; ServiceMaster identification card; any credit or fuel cards; and all tangible written or graphic materials (and all copies) relating in any way to ServiceMaster or its business, including, without limitations, documents, manuals, customer lists and reports, as well as all data contained on computer files, “thumb” drives, “cloud” services, or other data storage device, or home or personal computers.
		

		
			10.Assistance.  You agree that you will cooperate fully with ServiceMaster and its counsel with respect to any matter (including, but not limited to litigation, investigation or government proceeding) which relates to matters with which you were involved during your employment with ServiceMaster.  You further agree to notify ServiceMaster’s General Counsel or designee immediately upon your being asked to assist or supply information to any person or entity regarding any such matter, and also to give such notice in the event you do in fact assist or supply information to any such person or entity.
		

		
			11.Non‐Disparagement.  You agree that you will refrain from publicly criticizing ServiceMaster’s products and services and from otherwise making any false and malicious statements, oral or written, concerning ServiceMaster, its directors, officers, executives, subsidiaries, parent entities, and/or employees.  You agree to direct any prospective employers seeking to verify employment data to The Work Number (1‐800‐996‐7566 or www.theworknumber.com), an automated service operated by Equifax.  Nothing in this provision, however, shall be construed to prevent you from providing truthful testimony or information in response to any valid subpoena, court order, or request of any government agency or private litigant.
		

		
			12.Severability.  You and ServiceMaster agree that to the extent that any portion of this Agreement may be held to be invalid or legally unenforceable, the remaining portions will not be affected and will be given full force and effect.
		

		
			13.Arbitration.  Any dispute or controversy between you and ServiceMaster, whether arising out of or relating to this Agreement, the breach of this Agreement, or otherwise, shall be subject to the ServiceMaster We Listen Dispute Resolution Plan in effect on your Separation Date, which provides the mandatory and exclusive remedy and procedure for disputes between you and ServiceMaster.  Notwithstanding the foregoing, you agree that ServiceMaster may seek a temporary restraining order and/or preliminary injunction in any court of competent jurisdiction, without the posting of a bond, in order to preserve the status quo or to enforce the covenants in this Agreement.  You agree that venue shall be proper in Shelby County, Tennessee.
		

		
			14.Notices.  All notices required hereunder will be in writing and will be deemed given upon receipt if delivered personally (receipt of which is confirmed) or by courier service promising overnight delivery (with delivery confirmed the next day) or three business days after deposit in the U.S. Mail, certified with return receipt requested.  All notices will be addressed as follows:
		

			
					
						﻿

					
					
						 

				

		 

		

			5

		

		

			 

		

 

		

			 

		

		

			 

		

			
					
						If to you:

Alan J. M. Haughie 
xxxxxxxxxxxxxxxxx
xxxxxxxx, TN xxxxx

					
					
						If to ServiceMaster:

The ServiceMaster Company, LLC
860 Ridge Lake Boulevard
Memphis, TN 38120
Attn:     VP & Associate General Counsel,

					
						Labor and Employment

				

		
			﻿
		

		
			Or to such other address as either party will have furnished to the other in writing.
		

		
			15.Governing Law and Venue.  The interpretation, construction and performance of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Tennessee without regard to the principle of conflicts of laws.  Subject to the arbitration provisions herein, any judicial proceeding arising from and relating to this Agreement shall be brought in courts having competent jurisdiction located in the State of Tennessee, which shall be the exclusive forum for resolving such disputes.  Both parties consent to the personal jurisdiction of such courts for the purposes of this Agreement.
		

		
			16.Income Taxation.  You understand that the Company has not provided any advice regarding the tax liability resulting from this Agreement and you shall not rely upon any representations or policies of the Company related to taxation.  You are advised to seek the advice of your own personal tax advisor or counsel as to the taxability of any payments or other compensation contemplated by this Agreement.  ServiceMaster specifically disclaims that it has responsibility for the proper calculation or payment of any taxes which may be due other than for standard statutory withholding.
		

		
			17.Entire Agreement.  You and ServiceMaster agree that this Agreement constitutes the complete understanding between you and ServiceMaster regarding the matters herein and that no other promises or agreements, express or implied, will be binding between you and ServiceMaster unless signed in writing by you and ServiceMaster.  This Agreement fully supersedes and replaces any and all prior agreements or understandings, if any, between you and ServiceMaster on any matter that is addressed in this Agreement with the exception of confidentiality/non‐solicitation/non‐compete issues except as stated herein.
		

		
			18.Older Workers Benefit Protection Act Notice.  Pursuant to the Older Workers Benefit Protection Act, you are advised as follows:
		

		
			a.This Agreement includes a waiver of claims of age discrimination under the federal Age Discrimination in Employment Act;
		

		
			b.You have been advised and are again hereby advised to consult an attorney of your choosing before signing this Agreement;
		

		
			c.You have (i) 21 days from your receipt of this Agreement; or (ii) seven days from your Separation Date, whichever period is longer, to consider the Agreement (the “Review Period”);
		

		 

		

			6

		

		

			 

		

 

		

			 

		

		

			 

		

		
			d.You have seven days after you sign this Agreement to revoke the Agreement.  If you want to revoke this Agreement, you must deliver a written revocation to The ServiceMaster Company, LLC, 860 Ridge Lake Blvd., Memphis, TN 38120 Attn:  Vice President and Associate General Counsel, Labor & Employment;
		

		
			e.If your executed Agreement is not received by the Company within seven days from the end of the Review Period, the Agreement and any promises offered on behalf of Company contained therein will be null and void.
		

		
			19.Effective Date:  This Agreement becomes effective on the 8th day after you sign, provided you do not revoke the Agreement as provided above (such date, the “Effective Date”).
		

		
			HAVING ELECTED TO SIGN THIS SEPARATION AGREEMENT AND GENERAL RELEASE, TO FULFILL THE PROMISES AND TO RECEIVE THE SEVERANCE BENEFITS CONTEMPLATED HEREIN, YOU FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION AND AFTER BEING ADVISED TO SEEK ASSISTANCE OF LEGAL COUNSEL, ENTER INTO THIS AGREEMENT.
		

		
			﻿
		

			
					
						﻿

					
					
						 

					
					
						 

					
					
						 

				
	
					
						   /s/ Alan J. M. Haughie

					
					
						  

					
					
						   /s/ Susan Hunsberger

					
					
						  

				
	
					
						Alan J. M. Haughie

					
					
						 

					
					
						Susan Hunsberger

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						 

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						Senior Vice President, Human Resources

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						The ServiceMaster Company, LLC

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						 

					
					
						 

				
	
					
						Date:  March 6, 2017

					
					
						 

					
					
						Date:  March 6, 2017

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						 

					
					
						 

				

		
			﻿
		

		
			﻿
		

		 

		

			7Exhibit 10.4

 

EMPLOYMENT TERMINATION AND RELEASE AGREEMENT

This Employment Termination and Release Agreement (the “Agreement”) is entered into as of February 21, 2017 by and between Karen Chapman (“Employee”) OncoCyte Corporation (“OncoCyte”) and BioTime, Inc. (“BioTime”).

Recitals

A.            Employee is resigning as an officer and employee of OncoCyte, BioTime and any applicable BioTime subsidiaries for which she may have performed services.

B.            OncoCyte, BioTime, and Employee wish to provide for a resolution of any claim that Employee may have against OncoCyte, BioTime and BioTime subsidiaries.

Based on these recitals, the parties agree as follows:

Agreement

1.             Employment Termination Arrangements.

(a)          Employee agrees that her employment with OncoCyte, BioTime, and each of BioTime’s subsidiaries, if any, for which Employee performed services or by which she was employed (each a “Related Company”) will terminate effective at the close of business on March 22, 2017 (the “Termination Date”) as a result of her resignation.  Employee agrees that (i) she has been paid in full for all salary, wages, bonus payments (if any), accrued sick leave, accrued vacation, paid time off, and other compensation (collectively, “Compensation”) owed by OncoCyte, BioTime and any Related Company pursuant to her existing Employment Agreement dated as of April 1, 2011 and any other agreement or arrangement (written or oral) that may exist between Employee and OncoCyte, BioTime and any Related Company (the “Employment Agreement”) through the date of this Agreement, and (ii) BioTime and the Related Companies will not owe Employee any further or additional Compensation of any kind after the date of this Agreement.  Employee agrees that the only additional or further Compensation that OncoCyte will owe Employee after the date of this Agreement will be regular installments of her regular OncoCyte base salary through the Termination Date, any paid time off from OncoCyte remaining unused or unpaid on the Termination Date, coverage by any OncoCyte employee benefit plans available for all OncoCyte employees generally through the Termination Date, and the bonus payment referenced in Section 1(b) below.  Employee acknowledges and agrees that she is entitled to receive no other payments, benefits, or Compensation of any kind from OncoCyte, BioTime or any Related Company for services as an officer or employee of OncoCyte, BioTime or any Related Company.

(b)          Employee agrees that she will be using paid time off days from March 13 through March 22, 2017 and that she will receive payment for any remaining unused paid time off days from OncoCyte in her final paycheck in accordance with OncoCyte’s regular practices.

(b)          OncoCyte agrees that Employee shall receive from OncoCyte an annual bonus in the amount of $69,000 based on her performance as an OncoCyte employee, which shall be paid on or about March 10, 2017.  Employee agrees that she is not entitled to receive a bonus from BioTime or any Related Company or a bonus in excess of $69,000 from OncoCyte.

(c)          Employee, BioTime and OncoCyte agree that execution and delivery of this Agreement by Employee shall constitute the 30 day notice of resignation required by her Employment Agreement, and that she is resigning in all capacities as an officer or employee of OncoCyte, BioTime and any Related Company for which she may have been employed or performed services.

(d)          Employee currently holds the following employee stock options that were granted by OncoCyte, BioTime, or certain Related Companies:

OncoCyte Options

	
Grant Date

	 	
 Adjusted Strike Price for Reverse Stock Split

	 	
 O/S After Reverse Stock Split

	 	
Vesting 

Start date

	 	
Vested

as of

DOT*

	 	
Unvested and forfeited

immediately at DOT*

	 	
Cancelled if not exercised by February 28, 2018

	
4/1/2011

	 	
$   1.50

	 	
200,000

	 	
4/1/2011

	 	
200,000

	 	
-

	 	
200,000

	
1/9/2015

	 	
$   2.20

	 	
100,000

	 	
1/9/2015

	 	
54,166

	 	
45,834

	 	
54,166

	
2/16/2016

	 	
$   3.06

	 	
60,000

	 	
2/16/2016

	 	
16,250

	 	
43,750

	 	
16,250

	 	 	 	 	 	 	 	 	
270,416

	 	
89,584

	 	
270,416

BioTime Options

	
Grant Date

	 	
 Exercise Price

	 	
Total Granted

	 	
Vesting 

Start date

	 	
Vested

as of

DOT*

	 	
Unvested and forfeited

immediately at DOT*

	 	
Cancelled if not exercised in 90 days

	
9/1/2011

	 	
$     4.61

	 	
10,000

	 	
9/1/2011

	 	
10,000

	 	
-

	 	
10,000

	
2/202013

	 	
$     4.22

	 	
25,000

	 	
1/1/2013

	 	
25,000

	 	
-

	 	
25,000

	
3/20/2014

	 	
$     3.51

	 	
25,000

	 	
3/20/2014

	 	
18,750

	 	
6,250

	 	
18,750-

	 	 	 	 	 	 	 	 	
53,750

	 	
6,250

	 	
53,750

ReCyte Therapeutics, Inc. Options

	
Grant Date

	 	
 Exercise

Price

	 	
Total

Granted

	 	
Vesting 

Start date

	 	
Vested

as of

DOT*

	 	
Unvested and forfeited

immediately at DOT*

	 	
Cancelled if not exercised in 90 days

	
7/1/2012

	 	
$      2.05

	 	
50,000

	 	
7/1/2012

	 	
50,000

	 	
-

	 	
50,000

OrthoCyte Corporation Options

	
Grant Date

	 	
 Exercise

Price

	 	
Total

Granted

	 	
Vesting 

Start date

	 	
Vested

as of

DOT*

	 	
Unvested and forfeited

immediately at DOT*

	 	
Cancelled if not exercised in 90 days

	
7/1/2012

	 	
$      0.08

	 	
50,000

	 	
7/1/2012

	 	
50,000

	 	
-

	 	
50,000

*DOT means Termination Date

As a result of Employee ceasing to be an employee of OncoCyte and BioTime, and any Related Companies, under the terms of the applicable stock option plans of OncoCyte, BioTime, and Related Companies that have granted stock options to Employee, and the stock option agreements governing those stock options, Employee’s stock options that have not vested on or before the Termination Date shall expire upon the termination of her employment on the Termination Date, and except as otherwise provided in Section 3 of this Agreement with respect to vested OncoCyte stock options, her vested stock options shall expire ninety (90) days after the Termination Date unless exercised by Employee by that date.

 

2

2.             Tax. Employee shall be responsible for the payment of all income taxes arising from any exercise of her stock options and sale of the common stock issued upon exercise.

3.             Special OncoCyte Stock Option Amendment; Lock-Up Agreements.

(a)          In consideration of Employee entering into this Agreement and performing her obligations and covenants under this Agreement, including but not limited to the provisions of paragraph (b) of this Section 3, OncoCyte agrees that Employee’s OncoCyte stock options are amended as follows:

(i)          The expiration date of the OncoCyte stock options that are vested on the date of this Agreement and any stock options that vest from the date of this Agreement through the Termination Date is extended to 5:00 p.m. Pacific Time on February 28, 2018, subject to Employee’s full and timely performance of all of her obligations and covenants under this Agreement;

(b)          As an inducement for OncoCyte agreeing to extend the expiration date of Employee’s OncoCyte vested stock options, Employee hereby acknowledges and agrees that during the “Lock-Up Period” Employee will not, without the prior written consent of OncoCyte (which consent may be granted or withheld in OncoCyte’s sole discretion): (i) offer, sell, contract to sell (with the exception that Employee may enter a 10b5-1 planned sale agreement during the Lock-Up Period, so long as the sale of the Lock-up Shares does not occur during the Lock-up Period and planned sale of Locked-up Shares commences after Lock-up Period is over), pledge, grant any option to purchase or otherwise dispose of (collectively, a “Disposition”) any “Lock-Up Shares;” and (ii) exercise or seek to exercise or effectuate in any manner any rights of any nature that Employee has or may have hereafter to require OncoCyte to register under the Securities Act of 1933, as amended (the “Act”) Employee’s sale, transfer or other disposition of any of the Lock-Up Shares. As used in this Agreement, “Lock-Up Shares” means OncoCyte stock options held by Employee as defined by the table below:

OncoCyte Options

	
Grant Date

	 	
 Adjusted Strike Price for Reverse Stock Split

	 	
 O/S After Reverse Stock Split

	 	
Vesting 

Start date

	 	
Vested

as of

DOT*

	 	
Unvested and forfeited immediately at DOT*

	 	
Cancelled if not exercised by February 28, 2018

	
4/1/2011

	 	
 $   1.50

	 	
200,000

	 	
4/1/2011

	 	
200,000

	 	
-

	 	
200,000

	
1/9/2015

	 	
 $   2.20

	 	
100,000

	 	
1/9/2015

	 	
54,166

	 	
45,834

	 	
54,166

	
2/16/2016

	 	
 $   3.06

	 	
60,000

	 	
2/16/2016

	 	
16,250

	 	
43,750

	 	
16,250

	 	 	 	 	 	 	 	 	
270,416

	 	
89,584

	 	
270,416

“Lock-Up Shares” only applies to OncoCyte stock options held by Employee and excludes any stock options or shares held by spouse.

 

3

As used in this Agreement, “Lock-Up Period” means a period of time commencing on the date of this Agreement and ending at 5:00 p.m. Pacific Time on May 31, 2017. The foregoing restrictions under this paragraph are expressly agreed to preclude Employee from engaging in any hedging, collar (whether or not for any consideration) or other transaction that is designed to or reasonably expected to lead or result in a Disposition of Lock-Up Shares during the Lock-Up Period, even if such Lock-Up Shares would be disposed of by someone other than Employee. Such prohibited hedging or other transactions would include any short sale or any purchase, sale or grant of any right (including any put or call option or reversal or cancellation thereof) with respect to any Lock-Up Shares or with respect to any security (other than a broad-based market basket or index) that includes, relates to or derives any significant part of its value from Lock-Up Shares. Notwithstanding Employee’s agreement not to make any Disposition during the Lock-Up Period, the foregoing restrictions under this paragraph shall not apply to: (i) any transfers made by Employee by will or intestate succession upon the death of Employee, or (ii) a transfer to OncoCyte in connection with the exercise of any OncoCyte stock option, or (iii) any transfers made by the spouse of the Employee of options or shares currently held in his name. Employee may enter a 10b5-1 planned sale agreement during the Lock-Up Period, so long as the sale of the Lock-up Shares does not occur during the Lock-up Period and planned sale of Locked-up Shares commences after Lock-up Period is over.

(c)          Employee acknowledges and agrees that she will promptly comply in all respects with Section 6 of her Employment Agreement by returning to OncoCyte, BioTime and all Related Companies (i) all equipment and other property belonging to OncoCyte, BioTime and the Related Companies, (ii) all originals and copies of Confidential Information as defined in her Employment Agreement, and (ii) any and all other documents, information, and other items referenced in Section 6 of her Employment Agreement, to the extent any of the foregoing have not been returned to OncoCyte, BioTime, and all Related Companies on or before the Termination Date.

4.             Confidential and Proprietary Information.

(a)          During her employment with OncoCyte and BioTime, Employee had access to trade secrets and confidential information of OncoCyte, BioTime and certain Related Companies. Confidential Information means all information and ideas, in any form, relating in any manner to matters such as: products; formulas; technology and know-how; inventions; diagnostic test development and trial plans and data; clinical trial development plans and data, business plans; marketing plans; the identity, expertise, and compensation of employees and contractors; systems, procedures, and manuals; customers; suppliers; joint venture partners; research collaborators; licensees; and financial information. Confidential Information also shall include any information of any kind, whether belonging to OncoCyte, BioTime, a Related Company, or any third party, that OncoCyte, BioTime, or a Related Company has agreed to keep secret or confidential under the terms of any agreement with any third party. Confidential Information does not include: (i) information that is or becomes publicly known through lawful means other than unauthorized disclosure by Employee; (ii) information that was rightfully in Employee’s possession prior to this employment with OncoCyte or BioTime and was not assigned to OncoCyte, BioTime, or a Related Company, or was not disclosed to Employee in Employee’s capacity as an employee or other fiduciary of OncoCyte, BioTime; or a Related Company, or (iii) information disclosed to Employee, after the Termination Date without a confidential restriction by a third party who rightfully possesses the information and did not obtain it, either directly or indirectly, from OncoCyte, BioTime or a Related Company, and who is not subject to an obligation to keep such information confidential for the benefit of OncoCyte, BioTime, a Related Company, or any third party with whom OncoCyte, BioTime, or a Related Company has a contractual relationship. Employee understands and agrees that all Confidential Information shall be kept confidential by Employee on and after the Termination Date notwithstanding that her employment by OncoCyte, BioTime, and the Related Companies has terminated, and Employee further agrees that Employee (i) will not, without the prior written approval by OncoCyte, BioTime, and the respective Related Companies disclose any Confidential Information, or use any Confidential Information in any way, and (ii) Employee shall return to OncoCyte, BioTime, or a Related Company all originals and copies of Confidential Information belonging to such companies.

 

4

(b)          Employee agrees to keep the terms of this Agreement strictly confidential and will not disclose such information, without the prior written permission of OncoCyte and BioTime, to anyone except Employee’s attorneys or tax advisors, if any, but only after informing those persons that they too must keep the information confidential, unless and until (i) OncoCyte or BioTime discloses the material terms of this Agreement in a report or registration statement filed with the Securities and Exchange Commission under the Securities Exchange Act 1934, as amended, or under the Act, or (ii) Employee is required by court order or other law to disclose the terms of this Agreement.

5.             Release. Employee, on behalf of herself and her heirs, executors, administrators, and assigns, releases and discharges OncoCyte, BioTime, each Related Company, and each of the former, current or future officers, directors, employees, agents, fiduciaries, shareholders, insurers, and benefit plans of OncoCyte, BioTime and each Related Company from any and all claims, liabilities, causes of action, damages, losses, demands or obligations (“Claims”) of every kind and nature, whether now known or unknown, suspected or unsuspected, which Employee ever had, now has, or hereafter may have by reason of any act, omission, transaction, practice, conduct, or matter of any kind whatsoever, relating to or based upon, in whole or in part, Employee’s employment or termination of employment with OncoCyte, BioTime or any Related Company, except for “Excluded Claims.” As used in this Agreement, “Excluded Claims” mean Employee’s right to receive from OncoCyte regular installments of her regular base salary through the Termination Date, any paid time off remaining unused or unpaid on the Termination Date, coverage by any OncoCyte employee benefit plans available for all OncoCyte employees generally through the Termination Date, and the bonus payment referenced in Section 1(b). This release and discharge includes, but is not limited to, all Claims arising under federal, state and local statutory or common law, including, but not limited to, the Age Discrimination in Employment Act, Title VII of the Civil Rights Act of 1964, the California Fair Employment and Housing Act, Claims for wrongful discharge under any public policy or any policy of OncoCyte, BioTime or any Related Company, Claims for breach of fiduciary duty, and the laws of contract and tort, and any Claim for attorney’s fees. Employee promises never to file a lawsuit or assist in or commence any action asserting any Claims released hereunder. Not withstanding the above, Employee does not release OrthoCyte Corporation or its parent BioTime from claims related to employee’s rights as a shareholder of OrthoCyte Corporation.

6.             Known or Unknown Claims. Employee understands and expressly agrees that the provisions of Sections 5 and 6 of this Agreement extend to all Claims of every nature and kind, known or unknown, suspected or unsuspected, past, present, or future, other than Excluded Claims, arising from or attributable to any conduct of OncoCyte, BioTime, any Related Company, and any of their respective officers, directors, employees, agents, fiduciaries, shareholders, insurers, and benefit plans, whether or not Employee knows or believes she may have any Claims. Employee hereby WAIVES any and all rights granted to Employee under Section 1542 of the California Civil Code or any analogous state law or federal law or regulations. Section 1542 of the California Civil Code reads as follows:

 

5

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.

7.             No Disparagement. Employee agrees not to disparage OncoCyte, BioTime or any Related Company or any of their respective officers, employees, agents or representatives, and will not knowingly say or do anything that would have an adverse impact on OncoCyte, BioTime, or any Related Company. .

8.             Dispute. It is the intention of Employee, OncoCyte, BioTime, and the Related Companies that the Federal Arbitration Act and the California Arbitration Act shall apply with respect to the arbitration of disputes, claims, and controversies pursuant to, arising under, or in connection with this Agreement. Should a dispute arise concerning this Agreement or its performance, such dispute shall be resolved, at the election of the party seeking to enforce the Agreement, either by court action, or by binding arbitration administered by JAMS under its applicable dispute resolution rules. If arbitration is initiated, the arbitration shall be held in San Francisco or Oakland, California. The Company or BioTime shall pay the arbitrator’s fees and costs. Employee shall pay for Employee’s own costs and attorneys' fees, if any and the Company and BioTime shall pay for their own costs and attorneys' fees, if any, subject to the right of the prevailing party to recover its reasonable attorneys’ fees and costs as provided in Section 10.

EMPLOYEE UNDERSTANDS AND AGREES THAT THIS AGREEMENT TO ARBITRATE CONSTITUTES A WAIVER OF EMPLOYEE’S RIGHT TO A TRIAL BY JURY OF ANY MATTERS COVERED BY THIS AGREEMENT TO ARBITRATE

9.             Construction. This Agreement shall be construed and enforced in accordance with the laws of the State of California.

10.           Attorneys’ Fees. Should any action be brought by any party to this Agreement to enforce any provision of this Agreement, the prevailing party shall be entitled to recover, in addition to any other relief, reasonable attorneys’ fees and costs and expenses of litigation or arbitration.

11.           The terms of this agreement apply individually to Employee and do not affect the individual and separable rights of the Employee’s spouse.

12.           Integration. This Agreement constitutes an integration of the entire understanding and agreement of the parties with respect to the matters referred to in this Agreement. Any representation, warranty, promise or condition, whether written or oral, between the parties with respect to the matters referred to in this Agreement which is not specifically incorporated in this Agreement shall not be binding upon any of the parties hereto and the parties acknowledge that they have not relied, in entering into this Agreement, upon any representations, warranties, promises or conditions not specifically set forth in this Agreement. No prior or contemporaneous oral or written understanding, covenant, or agreement between the parties, with respect to the matters referred to in this Agreement, shall survive the execution of this Agreement. This Agreement may be modified only by a written agreement executed by both parties hereto.

 

6

13.           Successors and Assigns. This Agreement shall be binding on, and shall inure to the benefit of, Employee and OncoCyte, BioTime, each Related Company, and their respective heirs, executors, successor and assigns. The provisions of Sections 5, 6, and 7 shall also inure to the benefit of each of the former, current and future officers, directors, employees, agents, fiduciaries, shareholders, insurers, and benefit plans of OncoCyte, BioTime, and each Related Company and their respective heirs, executors, successors, and assigns.

14.           Construction. The language of this Agreement shall be construed as to its fair meaning and not strictly for or against either party.

15.           Counterparts. This Agreement may be executed in counterparts and when each party has signed and delivered at least one such counterpart, each counterpart shall be deemed an original and all counterparts taken together shall constitute one and the same Agreement, which shall be binding and effective as to all parties.

16.           Headings. Headings in this Agreement are for convenience of reference only and are not a part of the substance hereof.

17.           Severability. If any provision of this Agreement is held to be invalid, void or unenforceable, the remaining provisions shall remain in full force and effect, except that, should Section 5 or Section 6 be held invalid, void or unenforceable, either jointly or separately, as a result of any action by Employee, the Company shall be entitled to rescind the Agreement.

18.           Effective Date of Agreement

EMPLOYEE IS ADVISED THAT EMPLOYEE HAS UP TO TWENTY-ONE (21) CALENDAR DAYS TO CONSIDER THIS AGREEMENT IN WHICH EMPLOYEE WAIVES IMPORTANT RIGHTS, INCLUDING THOSE UNDER THE AGE DISCRIMINATION AND EMPLOYMENT ACT OF 1967. EMPLOYEE ALSO IS ADVISED TO CONSULT WITH AN ATTORNEY PRIOR TO EMPLOYEE’S SIGNING OF THIS AGREEMENT.

EMPLOYEE MAY REVOKE THIS AGREEMENT FOR A PERIOD OF SEVEN (7) CALENDAR DAYS FOLLOWING THE DAY EMPLOYEE SIGNS THIS AGREEMENT. ANY REVOCATION WITHIN THIS PERIOD MUST BE SUBMITTED, IN WRITING, TO WILLIAM ANNETT, CHIEF EXECUTIVE OFFICER, ONCOCYTE CORPORATION, AND TO ADITYA MOHANTY, CO-CHIEF EXECUTIVE OFFICER, BIOTIME, INC., 1010 ATLANTIC AVENUE, SUITE 102, ALAMEDA, CA 94501 AND STATE, "I HEREBY REVOKE MY ACCEPTANCE OF OUR EMPLOYMENT TERMINATION AND RELEASE AGREEMENT AND RELEASE OF ALL CLAIMS." THE REVOCATION MUST BE PERSONALLY DELIVERED TO WILLIAM ANNETTT, CHIEF EXECUTIVE OFFICER ONCOCYTE CORPORATION, AND TO ADITYA MOHANTY, CO-CHIEF EXECUTIVE OFFICER, BIOTIME, INC., 1010 ATLANTIC AVENUE, SUITE 102, ALAMEDA, CA 94501AND POSTMARKED WITHIN SEVEN (7) CALENDAR DAYS AFTER EMPLOYEE SIGNS THIS AGREEMENT.

 

7

PROVIDED THAT EMPLOYEE HAS NOT REVOKED THIS AGREEMENT, PURSUANT TO THE PRECEDING PARAGRAPH, THE EFFECTIVE DATE OF THIS AGREEMENT SHALL BE THE DAY AFTER THE EMPLOYEE HAS DELIVERED A SIGNED COPY OF THE AGREEMENT TO WILLIAM ANNETT, CHIEF EXECUTIVE OFFICER. ONCOCYTE CORPORATION, AND TO ADITYA MOHANTY, CO-CHIEF EXECUTIVE OFFICER, BIOTIME, INC., 1010 ATLANTIC AVENUE, SUITE 102, ALAMEDA, CA 94501.

IN WITNESS WHEREOF the parties have entered into this Agreement as of the date first above written.

	
/s/ Karen Chapman

	 
	
Karen Chapman

	 
	 	 	 
	
Address:

		 
	 		 

 

	
BioTime, Inc.

	 
	 	 	 
	
By:

	
/s/ Editya P. Mohanty

	 
	 	 	 
	
Title:

	
Co-CEO

	 
	 	 	 
	
OncoCyte Corporation

	 
	 	 	 
	
By:

	
/s/ William Annett

	 
	 	 	 
	
Title:

	
CEO

	 

  

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}]]